GTG 0.00% 3.9¢ genetic technologies limited

News: GTG Genetic Technologies Files Provisional Patent For Its COVID-19 Severity Risk Test With..., page-44

  1. 10,506 Posts.
    lightbulb Created with Sketch. 1053
    Mate have you been living in Mars? Having a test that can assess potential high risk patients in greater detail will ensure that the vulnerable sector can be further focused upon. This will make it easier to open up societies as currently it’s about protecting broad sectors - from elderly to co-morbidities. The addition of blood types and genetic correlations not only can help in the measures to manage this pandemic, it also becomes part of a large research body of this virus. To have a risk assessment test required greater understanding on the mechanisms of how the virus functions.
    Finally a CR above closing price? Wow.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.